Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer: A Prospective Randomized Clinical Trial (PET START Trial)

NCT00136864 is registered in ClinicalTrials.gov with Ontario Clinical Oncology Group (OCOG) as lead sponsor.

NCT NCT00136864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00136864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer: A Prospective Randomized Clinical Trial (PET START Trial)
Lead sponsor
Ontario Clinical Oncology Group (OCOG)
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2004
Completion date
September 30, 2011
Enrollment
310 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

non-small-cell lung carcinoma